Key facts
- This page summarizes Sanford R. Simon's Form 4 filing for APPLIED DNA SCIENCES INC (APDN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 27 Jan 2023, 15:17.
Sanford R. Simon - 25 Jan 2023 Form 4 Insider Report for APPLIED DNA SCIENCES INC (APDN)
- Reporting relationship
- Director
- Issuer ticker
- APDN
- Reported as of
- 25 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Jan 2023, 15:17:42 UTC
- Prior SEC filing
- 03 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Beth Jantzen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sanford R. Simon filed Form 4 for APPLIED DNA SCIENCES INC (APDN) on 27 Jan 2023.
Change
- Previous filing in this sequence was filed on 03 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APDN
transaction
Derivative
Incentive Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,099
- Change %
- Price
- $0.000000
- Shares after
- 75,099
- Date
- 25 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,099
- Exercise price
- $1.41
- Footnotes
- F1
APDN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +38,489
- Change %
- Price
- $0.000000
- Shares after
- 38,489
- Date
- 25 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 38,489
- Exercise price
- $1.41
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date.